Presenilins regulate T cell development by modulating TCR signaling
Presenilins regulate T cell development by modulating TCR signaling
复制标题
DOI:
--
复制
发表时间:
2007
期刊:
影响因子:
--
通讯作者:
K. Laky;B. Fowlkes
中科院分区:
文献类型:
--
作者:
K. Laky;B. Fowlkes
Vol. 204, No. 9, September 3, 2007 2115-2129 www.jem.org/cgi/doi/ 2115 10.1084/jem.20070550 Upon recognition of MHC ligands on thymic stroma, TCR signaling in CD4 CD8 (double-positive [DP]) thymocytes mediates positive selection and the development of CD4 and CD8 T cells. There is broad support for quantitative models in which the strength/ duration of TCR signals determines the fate of a DP thymocyte. Accordingly, the strongest TCR signals induce negative selection by deletion; intermediate TCR signals promote positive selection and maturation to the single-positive (SP), CD4 CD8 or CD4 CD8 , stage; and weak or no TCR signals result in cell death. The quantity of the TCR signal has also been proposed to be a primary determinant in CD4 and CD8 lineage commitment. Among DP thymocytes receiving TCR signals within the range for positive selection, those receiving stronger/prolonged signals are biased toward the CD4 fate, whereas those experiencing weaker/ transient signals adopt the CD8 fate ( 1-3 ). A provocative and lingering topic in this fi eld is how quantitatively diff erent TCR signals in DP thymocytes are translated intracellularly to specify these T cell fates. The Notch signaling pathway is another important regulator of cell fate in thymocytes. Notch is essential for commitment of lymphoid precursors to the T cell lineage. Notch signaling is required in double-negative (DN) CD4 CD8 thymocytes for maturation through the DN1 – DN4 stages, where it has been associated with such critical functions as TCR rearrangement, pre-TCR signaling, and / T lineage commitment ( 4-12 ). Notch has also been implicated in the subsequent CD4 versus CD8 lineage decision that is initiated in DP thymocytes ( 13 – 15 ). Collectively, these data suggest that recurrent/ continuous Notch signaling may be required throughout thymocyte development. Nevertheless, several experimental approaches have yielded confl icting results on the role of Notch signaling in the late stages of T cell development. Development of SP thymocytes is normal in mice defi cient for individual Notch family members ( 16 – 19 ). Inhibiting Notch signaling either by conditional deletion of the transcriptional regulator CBF1/Su(H)/Lag-1 (CSL; also called RBPJ ) or expression of a dn form of the transcriptional coactivator Mastermind (dnMAML), were also reported to have no effect on CD4/CD8 T cell fate ( 7, 20 ). Likewise, overexpression of Numb, which is an antagonist of Notch, has no obvious eff ect on development ( 21 ). In contrast to these negative results, other studies imply that Notch does play a role in CD4 and CD8 T cell development. When pharmacological inhibitors were added to fetal thymic organ cultures to block Notch activation, the authors of two independent studies concluded that Notch activity promotes CD8 CORRESPONDENCE B.J. Fowlkes: bfowlkes@nih.gov